Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Defense
Grant: W81XWH1910002
National Institutes of Health
Grant: R35 GM 124909
Memorial Sloan-Kettering Cancer Center
Grant: P30 CA 008748
National Institutes of Health
Grant: 5R35GM124909-05
Investigating long noncoding RNAs as regulators of the p53 pathway functions.
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals